PSTV

#4002
PLUS THERAPEUTICS, Inc. - Common Stock
5.8 2 USD
-9.49%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
5.82
5.82
년간 변동
0.13
8.00
일일 변동
-9.49%
월간 변동
+4.49%
6달 변화
+854.10%
년간 변동율
+1906.90%
이전 종가
6.4 3
Open
5.8 2
저가
5.8 2
High
5.8 2
양
22
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
손익계산서 대차대조표 현금 흐름
값 Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

PLUS THERAPEUTICS, Inc. - Common Stock

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®.

뉴스